Hematology NewsFDA expands dasatinib indication to children with Ph+ ALLJanuary 3, 2019ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA approves dasatinib for kids with Ph+ ALLJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesGroup proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsQuizartinib improves survival of FLT3-mutated AMLJanuary 2, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA approves first treatment for BPDCNDecember 26, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves calaspargase pegol-mknl for ALLDecember 24, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Oncology PracticeFDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasmDecember 21, 2018Rare DiseasesALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCHMP backs dasatinib for kids with newly diagnosed ALLDecember 19, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesKTE-X19 induces durable CRs, MRD negativity in ALLDecember 17, 2018Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesCombo bests standard care in younger CLL patientsDecember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesPreliminary data suggest UCART19 is safe, effectiveDecember 12, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsIbrutinib-rituximab ‘new standard of care’ in younger CLL patientsDecember 11, 2018CLLLeukemia, Myelodysplasia, TransplantationAggressive Lymphomas
Hematology TimesEarly switch to dasatinib offers clinical benefit to CML patientsDecember 10, 2018Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesAlgorithm uncovers DS in AML patients on IDH inhibitorsDecember 7, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDasatinib re-challenge feasible as 2nd attempt at TKI discontinuationDecember 7, 2018Leukemia, Myelodysplasia, TransplantationCML
